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We show that Ca2+/calmodulin(CaM)-dependent protein kinase I (CaMKI) is directly inhibited by its
S-glutathionylation at the Cys179. In vitro studies demonstrated that treatment of CaMKI with dia-
mide and glutathione results in inactivation of the enzyme, with a concomitant S-glutathionylation
of CaMKI at Cys179 detected by mass spectrometry. Mutagenesis studies conﬁrmed that S-glutath-
ionylation of Cys179 is both necessary and sufﬁcient for the inhibition of CaMKI by diamide and glu-
tathione. In transfected cells expressing CaMKI, treatment with diamide caused a reversible
decrease in CaMKI activity. Cells expressing mutant CaMKI (179CV) proved resistant in this regard.
Thus, our results indicate that the reversible regulation of CaMKI via its modiﬁcation at Cys179 is
an important mechanism in processing calcium signal transduction in cells.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction activities. However, redox regulation of CaMKI has yet to be eluci-The Ca2+/CaM (calmodulin)-dependent kinases (CaMKs) play
critical roles in processing transduction by enhancing intracellular
Ca2+ [1,2]. Among them, multifunctional CaMKs, such as CaMKI
and CaMKII, are present in most mammalian tissues but are partic-
ularly abundant in brain, where they phosphorylate and regulate
numerous protein substrates [3]. Binding of Ca2+/CaM to CaMKI
and CaMKII allows autophosphorylation of CaMKII or phosphoryla-
tion of CaMKI by the upstream Ca2+/calmodulin-dependent protein
kinase kinase (CaMKK). This phosphorylation increases their Ca2+/
CaM-dependent activity of CaMKI but not of CaMKII. CaMKII, but
not CaMKI, can also exhibit signiﬁcant Ca2+-independent activity
[4,5]. Thus, the regulation of CaMKs by conventional means re-
quires binding of Ca2+/CaM to and phosphorylation of the enzymes
to initiate the process. Site-speciﬁc methionine oxidation of [6] and
thiol nitrosylation of CaMKII [7] have also the ability to affect theirchemical Societies. Published by E
lmodulin-dependent protein
inase kinase; DTT, dithiothre-
ion
tanabe).dated. For the present paper, we investigated molecular mecha-
nisms of oxidant dependent regulation of CaMKI in CaMKI
expressing cells and demonstrated S-glutathionylation-mediated
inactivation of the enzyme.
2. Materials and methods
2.1. Materials
Recombinant GST-fused CaMKIa [8] and CaMKKa [9] were ex-
pressed in Escherichia coli DH5a and puriﬁed as described previ-
ously. The coding region of CaMKIa cDNA in pGEX-4T3 [8] was
digested with EcoRI and NotI, and then subcloned into pGEX-6P3
and transformed into E. coli DH5a. The constitutively active con-
struct, CaMKI (I286D, V290D, I294D, F298A, F307A) was provided
by Dr. Takeo Saneyoshi (Brain Science Institute, RIKEN, Saitama, Ja-
pan). Puriﬁcation of GST-cleaved CaMKIa was performed using
PreScission protease as described in the manufacturer’s protocol.
Recombinant rat CaM was expressed in E. coli BL21 (DE3) and
puriﬁed using pET-CM, kindly provided by Dr. Nobuhiro Hayashi
(Fujita Health University, Toyoake, Japan) [10]. [c-32P] ATP
(6000 Ci/mmol) was from GE Healthcare (Piscataway, NJ, USA)lsevier B.V. All rights reserved.
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tained from Takara Shuzo (Osaka, Japan). The rabbit anti-CaMKI
polyclonal antibody (pAb) was kindly provided by Dr. Angus C.
Nairn (Yale University School of Medicine, New Haven, CT, USA)
[11]. Monoclonal antibodies speciﬁc to phosphorylated CaMKI (p-
CaMKI, threonine 177) were generated from immunized mice.
Monoclonal antibodies recognizing glutathionylated proteins
(anti-protein S-glutathionylation (anti-PSSG) Ab) were obtained
from Virogen (Watertown, MA, USA).
2.2. Inactivation of CaMKI by diamide and GSH
Recombinant CaMKIa (0.1 mg/mL) was activated with CaMKKa
(4 lg/mL) at 30 C in 80 mM HEPES (pH 7.5), 5 mM MgCl2, 1 mM
CaCl2, 10 lM CaM, and 400 lM ATP. The reaction was terminated
at 20 min by 10-20-fold dilution with ice-cold 50 mM HEPES (pH
7.5), 10% ethylene glycol, and 2 mM EDTA. Activated wild-type or
mutant CaMKIa (5 lg/mL) were incubated at 25 C for 10 min in
50 mM HEPES (pH 7.5) and 2 mM EDTA with increasing amounts
of diamide (0–3.0 mM), in the presence of 125 lM glutathione
(GSH). An aliquot of reaction mixture was then removed and ana-
lyzed for activity. Kinase activity was measured at 30 C for 3 min
in 80 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM CaCl2, 10 lM CaM,
10 lM [c-32P] ATP, 40 lM synthetic peptide syntide-2 (PLAR-
TLSVAGLPCKK), and CaMKIa (1.5 lg/mL) in a ﬁnal volume of 25
32P incorporation was determined by spotting 20-lL aliquots onto
Whatman P-81 phosphocellulose paper followed by washing in
75 mM phosphoric acid [12]. For reversal with glutaredoxin
(AbFrontier, Seoul, Korea), following incubation with diamide and
GSH, human recombinant glutaredoxin-1 (0.04 mg/mL) and more
GSH (0.5 lM) were added.
2.3. Construction of plasmids
The plasmids pME18s-nNOS and a constitutively active con-
struct, pME18s-CaMKK1-434 was generated as described previ-
ously [13,14]. The CaMKIa mutants, 179CV, (the mutant featuring
replacement of Cys179 with Val) were generated with pGEX-6 P
CaMKIa plasmid DNA and a QuickChange II site-directed mutagen-
esis kit (Stratagene, La Jolla, CA, USA). The nucleotide sequences of
each mutant were conﬁrmed. Wild type CaMKIa and the 179CV
mutant were subcloned into the pME18s-FLAG vector [15].
2.4. Cell culture, transfection, and stimulation
HeLa cells and HEK-293 cells were maintained in Dulbecco’s
modiﬁed Eagle medium containing 10% fetal calf serum and sub-
cultured for 24 h in 6-cm dishes. They were then transfected with
the pME18sFLAG-CaMKIa (2 lg) construct alone or together with
pME18s-CaMKK1-434 construct (0.4 lg) using LipofectAMINE Plus
(Life Technologies, Inc.). After 24–36 h incubation, the cells were
serum starved for 18 h and stimulated with buffer alone or 1 mM
diamide for 10 min.
2.5. Preparation of lysates and immunoprecipitation
For preparation of lysates, cells were homogenized by sonica-
tion in TNE buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM
PMSF, 10 lg/mL leupeptin, 1 lg/mL pepstatin A, 1 lg/mL aprotinin,
1 mM sodium orthovanadate, 50 mM sodium ﬂuoride, 2 mM so-
dium pyrophosphate, and 1% Nonidet P40). After centrifugation
at 15000g for 15 min, the supernatant was added to 10 lL of
anti-FLAG M2-agarose afﬁnity gel (50% slurry) (Sigma, St. Louis,
MO, USA), and the mixture was incubated for 1 h at 4 C. After pre-
cipitation of the resin by centrifugation and removal of the super-
natant, resin was washed twice with 500 lL of TNE buffer. Thebeads were used for an in vitro kinase assays using syntide-2 as
the substrate. An aliquot of supernatant was also applied for
SDS–PAGE followed by Western blot analyses or for an in vitro ki-
nase assay. For the determination of glutathionylated CaMKIa, all
the procedures were performed without any reducing reagents.
2.6. Mass spectrometry analysis to identify S-glutathionylation sites in
CaMKI digests
Puriﬁed rat CaMKIa (5 lg) was treated with 125 lM GSH and
100 lM diamide in 1 mM EDTA and 250 mM HEPES-NaOH (pH
7.7) for 30 min at 25 C. GSH and diamide were removed, and buf-
fer was exchanged by 3 cycles of concentration–dilution in 20 mM
ammonium bicarbonate buffer (pH 8.0) using a microcentrifugal
concentration device with a 30-kDa cutoff membrane (Centricon,
Millipore). The protein was then digested at 25 C for 3 h with
combinations containing protease trypsin (Promega, Madison,
WI, USA), trypsin + chymotrypsin (Roche Applied Sciences, Penz-
berg Germany), trypsin+ endoproteinase Glu-C (Roche Applied Sci-
ences), trypsin+ endoproteinase Asp-N (Roche Applied Sciences), or
endoproteinase Asp-N+ endoproteinase Glu-C. Two volumes of
acetonitrile were added and the mixtures were dried in a speed
vacuum centrifuge. The dried digests were dissolved in 0.1% formic
acid and subjected to LC (liquid chromatography)-tandem mass
spectrometry (MS/MS) analysis, performed on a Q-Tof2 quadru-
pole/time-of-ﬂight hybrid mass spectrometer (Micromass)
interfaced with capillary reverse-phase liquid chromatography
(Micromass CapLCTM System) as described previously [16]. The ac-
quired MS/MS data were analyzed using the Mascot search engine
(Matrixscience) against the CaMKIa amino acid sequence (Gen-
BankTM accession number L26288). We set the search parameters
as follows: variable modiﬁcations, S-glutathionylation (C) (+305
Da); peptide tolerance, ±0.1 Da; MS/MS tolerance, ±0.1 Da.
2.7. Statistical analysis
The signiﬁcance of variability between the results from each
group and the corresponding control was determined by unpaired
t-test. Means ± S.E. were calculated.3. Results
3.1. CaMKI is fully inactivated by treatment with diamide and reduced
glutathione
In initial experiments we determined the effects of the thiol-
speciﬁc oxidant diamide with GSH on CaMKI enzyme activity. For
full activation, CaMKI requires phosphorylation of a crucial activa-
tion loop Thr177 by CaMKK [17]. Rat CaMKI (5 ng/lL) activated by
CaMKK was incubated with reduced GSH (125 lM) and diamide
(100 lM) for 10 min. and the activity of CaMKI was measured.
There was rapid and near complete loss in activity of CaMKI
(Fig. 1A). Addition of dithiothreitol (DTT) (20 mM, 10 min) com-
pletely reversed this inhibition. We next examined the effects of
diamide (0.01–3 mM) with GSH (125 lM) on CaMKI activity.
Fig. 1B shows concentration-dependent inactivation of CaMKI with
near complete inhibition in the presence of 0.1 mM diamide.
3.2. CaMKI is modiﬁed by S-glutathionylation, resulting in enzyme
inhibition
If this mode of regulation is physiologically signiﬁcant, then oxi-
dized forms of endogenous CaMKI, either glutathionylated or disul-
ﬁde linked dimeric form should be detectable in native tissues such
as brain. To determine whether glutathionylated CaMKI could be
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Fig. 1. CaMKI is inactivated by diamide/GSH. (A) Activated CaMKI was incubated (10 min at 25 C) with 125 lM GSH and 100 lM diamide. Samples were then assayed for
3 min using 50 lM syntide-2 and 1 mM CaCl2, 1 lM CaM, 10 lM [c-32P]ATP. For the DTT sample, an additional incubation with 20 mM DTT (10 min at 25 C) was performed
prior to assaying. Values are means ± S.E. (n = 3). (B) Activated CaMKI (5 ng/lL) was incubated (10 min at 25 C) with the indicated amounts of diamide in the presence of
125 lM GSH. The enzyme activity of CaMKI was measured as described in panel A. The means ± S.E. of three independent experiments are shown. Note that treatment of
activated CaMKI with 125 lM GSH and 100 lM diamide resulted in nearly complete inhibition of its enzyme activity (arrow).
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Fig. 2. CaMKI is rapidly and nearly completely inhibited upon being S-glutathionylated. (A) Activated CaMKI was incubated with 125 lM GSH and 100 lM diamide and
sample was subjected to Western blotting with anti-GSH (PSSG) and CaMKI (CaMKI) antibodies under the non-reducing condition. Note that the upper band around 150 kDa
appeared, which is likely an intermolecular dimmer (75 kDa: GST-fused CaMKI2), since this band disappears when all the procedures were performed under the reducing
condition. (B) Activated CaMKI was incubated with 125 lM GSH and 100 lM diamide as indicated. After the addition of buffer alone (open column) or 500 lM GSH plus
3.3 lM glutaredoxin (closed column) for 15 min at 25 C, the enzyme activity of CaMKI was measured. The means ± S.E. of three independent experiments are shown. Each
sample was subjected to Western blotting with anti-GSH (PSSG) and CaMKI (CaMKI) antibodies under non-reducing conditions. Note that the minor band appeared in the
third lane, which is likely oxidative modiﬁed CaMKI besides S-glutathionylation. The relative position of S-glutathionylated CaMKI is marked as an asterisk. (C) CaMKI was
initially incubated with 125 lM GSH and 100 lM diamide (10 min at 25 C) and then activated by CaMKK in the presence of 1 mM CaCl2, 1 lM CaM, and 200 lM ATP.
Samples were then subjected to Western blotting with anti-phospho-177Thr CaMKI (p-177Thr) and CaMKI (CaMKI) antibodies under reducing conditions. Proportional
amounts were subjected CaMKI assay. The means ± S.E. of three independent experiments are shown.
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incubated either with or without GSH and diamide for 10 min.
and then immunoblotted with a monoclonal antibody against
GSH protein adducts in the non-reduced condition. Treatment with
GSH and diamide did induce CaMKI S-glutathionylation (Fig. 2A).
Although S-glutathionylated CaMKI was evident in GSH and dia-
mide-treated enzyme, we questioned whether this modiﬁcation
is sufﬁcient to signiﬁcantly dampen CaMKI activity. The enzymethioltransferase (also known as glutaredoxin: Grx) selectively
dethiolates S-glutathionylated protein by a GSH-dependent mech-
anism [18]. We therefore investigated whether thioltransferase
catalysis could reverse GSH and diamide-potentiated CaMKI inacti-
vation. When activated CaMKI was incubated with GSH (125 lM)
and diamide (100 lM) for 10 min, its enzyme activity was inhib-
ited nearly completely. Treatment of Grx (3.3 lM) and GSH
(500 lM) with the glutathioylated CaMKI resulted in a substantial
Table 1
Glutathionylation of the protease-digested peptide which contains Cys residue The
CaMKIa protease-digested peptides sequences are DPGSVLSTACGTPGYVAPE,
STACGTPGYVAPEVL, STACGTPGYVAPEVLAQKPY, FTCEQALQHPW, and ELL-
TPTAGGPAAGC,with the modiﬁed cysteine residues indicated in bold and underlined.
Amino acid sequence Modiﬁcation ESI (m/z)
170–188 DPGSVLSTACGTPGYVAPE 1063.47
176–190 STACGTPGYVAPEVL 885.39
176–195 STACGTPGYVAPEVLAQKPY 786.38
265–275 FTCEQALQHPW 832.87
336–349 ELLTPTAGGPAAGC 781.86
T. Kambe et al. / FEBS Letters 584 (2010) 2478–2484 2481reactivation of kinase activity (Fig. 2B).We next examined whether
Grx and GSH reverse kinase inhibition by removal of GSH from
CaMKI. Activated CaMKI was inactivated with GSH and diamide
and then was analyzed by immunoblotting with a monoclonal
antibody against GSH protein adducts. The immunoreactive band
disappeared by the treatment with Grx and GSH (Fig. 2B). To deter-
mine whether S-glutathionylation of CaMKI effects CaMKK-in-
duced phosphorylation at Thr177, we ﬁrst pretreated CaMKI
either with or without GSH/diamide and analyzed CaMKK-induced
phosphorylation at Thr177 by immunoblotting using phosphospec-
iﬁc antibodies. As shown in Fig. 2C, pretreatment of CaMKI with
GSH and diamide had no effect on the phosphorylation at Thr177.
However, it did result in loss of CaMKI enzyme activity.
3.3. Cys179 is an essential site for inactivation of CaMKI
It is known that PKA is fully and reversibly inactivated by oxida-
tive S-glutathionylation at Cys199 [19]. This Cys199 in the subdo-
main VIII, often mentioned as a key protein kinase catalytic
domain indicator [20], is highly conserved among a number of ki-
nases including CaMKI (Cys179: based on the rat CaMKIa sequence).
We generated and puriﬁed a mutant CaMKI in which Val was
substituted for Cys179(179CV) and characterized both activity and
sensitivity to inhibition by GSH and diamide. We constructed and
puriﬁed CaMKIs by site-speciﬁc separation of the GST tag from pro-
teins expressed using pGEX-6P vectors (Fig. 3A). Both CaMKIs were
at least 90% pure and gave a major band at 45 kDa on SDS–PAGE
with Coomassie Brilliant Blue staining (Fig. 3B). Both the wild-type
and the 179CVmutant were activated by CaMKK to similar extents.
With increasing amounts of diamide (0–300 lM) in the presence of
GSH (125 lM) no remarkable decrease in activity was noted with
the 179CV mutant, while the wild-type was signiﬁcantly inacti-
vated (Fig. 3C). Rat brain CaMKIa contains nine Cys residues besides
Cys179. We further generated mutants of CaMKI, in which each of
the eight Cys residues besides Cys179 were replaced by Ser or Ala
and determined both activity and sensitivity to inhibition by GSH0
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Fig. 3. Generation of a redox-resistant CaMKI mutant. (A) Schematic illustration of CaMK
mutant from E. coli cells were separated by 10% SDS–PAGE and stained with Coomassie B
25 C) with the indicated amounts of diamide (0–300 lM) in the presence of 125 lM
independent experiments are shown.and diamide. The enzyme activities of wild-type and mutants were
similar in an in vitro assay. Treatment of the wild-type and these
mutants with GSH (125 lM) and diamide (100 lM) for 10 min re-
sulted in a nearly complete inhibition of enzyme activity (data not
shown).
3.4. Cys179 is the site of S-glutathionylation on CaMKI
To determine whether Cys179 is accessible to S-glutathionyla-
tion by treatment of GSH/diamide, we employed a MS-based meth-
od that can identify S-glutathionylated peptides in digests of GSH/
diamide-treated proteins. Following exposure of CaMKI to GSH/
diamide, the protease digestion was performed and peptides were
introduced by ESI (electrospray ionization) into a hybrid quadru-
pole time-of-ﬂight MS. ESI-MS was performed as stated in the
Materials and methods. We obtained peptide sequences that cov-
ered 73% of the entire amino acid sequence of CaMKIa (data not
shown). Among these peptides, ESI-MS of Cys179 containing pep-
tides (DPGSVLSTACGTPGYVAPE, STACGTPGYVAPEVL, STAC-
GTPGYVAPEVLAQKPY) from GSH/diamide-treated CaMKI showed
S-glutathionylated peptides (1063.47, 885.39, 786.38m/z, respec-
tively) (Table 1). Notably, other peptides (FTCEQALQHPW: Cys267,
ELLTPTAGGPAAGC: Cys349) were also all S-glutathionylated. The179CV
WT
Diamide (uM) 
+GSH
50 100 150 200 250 300 350
CaMKI
I. (B) equal amounts (0.5 lg) of GST-cleaved wild-type CaMKI (WT) and the 179CV
rilliant Blue. (C) Wild type (WT) or 179CV mutant CaMKI were incubated (10 min at
GSH then assayed for activity as described for Fig. 1. The means ± S.E. of three
2482 T. Kambe et al. / FEBS Letters 584 (2010) 2478–2484above results suggest that the S-glutathionylated CaMKI at Cys179
is responsible for inactivation by the treatment with GSH and dia-
mide in vitro.
Having discerned that S-glutathionylation of Cys179 inactivates
CaMKI, we tested whether CaMKI substrates (ATP, a synthetic pep-
tide: syntideII) and an activator (CaM) can protect against inactiva-
tion. None of them (ATP, syntideII, and CaM) afforded competitive
protection of CaMKI from inhibition. Table 2 summarized the prop-
erties of the wild-type CaMKI treated either with or without GSH
and diamide.
We next tested whether S-glutathionylation of Cys179 is sufﬁ-
cient to dampen CaMKI activity in cells. We expressed wild-type
or 179CV CaMKI in HeLa cells and monitored enzyme activity on
treatment with diamide (Fig. 4A). In the absence of treatment,
the enzyme activities of wild-type and 179CVmutant in the cell ly-
sates were similar. Diamide treatment led to a decrease in enzyme0
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FLAG-wild-type CaMKI (WT) or pME18s-FLAG-CaMKI (179CV). After 48 h, the cells we
15 min and then cell lysates were subjected to in vitro kinase assays using 50 lM syntide-
in the Mock transfected cells. The means ± S.E. of three independent experiments are show
construct, pME18s-CaMKK1-434 and pME18s-FLAG-wild-type CaMKI. After 48 h, the
immunoprecipitated samples were incubated (10 min at 25 C) with buffer alone (open c
(shaded column) and then subjected to in vitro kinase assays as described for panel A. Th
representative immunoblot of expression of CaMKI (CaMKI) and phospho-177Thr CaMK
CaMKI was also afﬁnity-puriﬁed from transfected cells using anti-Flag-agarose chromato
the non-reducing condition.
Table 2
Kinetic properties of diamide/GSH-untreated and -treated CaM-K I phosphorylation
reaction was carried out at 30 C for 3 min in a solution containing 40 lM syntide-2,
10 lM [c-32P]ATP, 1 lM CaM and 1 mM CaCl2 as standard condition (standard). The
values represent the means ± S.E. of three experiments.
Control Diamide/GSH
Activity (nmol/min/mg)
Standard 399 ± 28.7 5.27 ± 1.88
Excess CaM (10 lM) 364 ± 2.53 7.10 ± 0.37
Exxcess SyntideII (500 lM) 454 ± 24.2 28.8 ± 5.26
Excess ATP (100 lM) 1620 ± 48.3 46.8 ± 36.7activity when the wild-type enzyme was expressed (Fig. 4A). In
contrast, cells expressing C179V proved resistant to diamide,
although the treatment led to increase in phosphorylation at
Thr177 in both cases. Equal levels of the wild-type and the 179CV
mutant were expressed in HeLa cell lysates, indicating that the en-
zyme activity of CaMKI is regulated by the Cys179 modiﬁcation. We
further determined whether this Cys179 modiﬁcation could be S-
glutathionylation. We investigated whether thioltransferase catal-
ysis could reverse diamide-induced CaMKI inactivation. We ex-
pressed wild-type CaMKI and a constitutively active form of
CaMKK, CaMKK1-434 in HeLa cells and monitored the enzyme
activity. As shown in Fig. 4B, the decrease in CaMKI activity in HeLa
cells expressing wild-type CaMKI was reversed by treatment with
GSH and Grx. The treatment of diamide led to increase in S-glu-
tathionylation of CaMKI. We further examined the working of this
Cys179-sensitive redox signaling in situ. Our previous data showed
that CaMKI inhibits neuronal NO synthase (nNOS) enzyme activity
by adding phosphate groups to Ser741 on nNOS [21]. HEK-293 cells
were transfected with nNOS and a constitutively active form of
CaMKI or 179 CV constitutively active form of CaMKI, and lysates
were immunoblotted with phospho-Ser741 nNOS either with or
without 1 mM diamide treatment for 15 min. In the absence of
treatment, the nNOS phosphorylation was evident in both cells.
Treatment of the cells expressing a constitutively active form of
CaMKI with diamide led to a remarkable decrease in the nNOS
phosphorylation (Fig. 5A). In contrast, cells expressing 179CV
proved resistant to diamide, although the treatment led to increase
in CaMKI S-glutathionylation. We also analyzed whether the oxi-
dized forms of endogenous CaMKI was observed in native tissues.diamide- +
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or 1 mM diamide (+) for 15 min. Cell lysates were immnoblotted with anti-CaMKI (CaMKI) or anti- phospho-177Thr CaMKI (p-177Thr). Expressed nNOS and CaMKI were also
afﬁnity-puriﬁed from transfected cells using ADP- and anti-Flag-agarose chromatography technique, respectively (ADP, Flag) and subjected to immunoblotting with anti-
nNOS (nNOS), anti-phospho-741Ser nNOS (p-Ser741), and anti-GSH (PSSG). The data are representative of at least two independent experiments. (B) Crude extracts of mouse
brain were subjected to Western blotting with anti-CaMKI (CaMKI) antibody either with (+) or without () 100 mM DTT. The data are representative of at least two
independent experiments.
T. Kambe et al. / FEBS Letters 584 (2010) 2478–2484 2483Protein immunoblot analyses with anti-CaMKI antibody of mouse
brain lysates detected an immunoreactive band corresponding to
the 42-kDa under reducing conditions (Fig. 5B). When samples
are run under non-reducing conditions, it displays a discrete shift
in mobility, running faster. Thus, conformational changes induced
by an internal disulﬁde are indicative of such mobility shifts.
4. Discussion
In the present study, we generated evidence that CaMKI is sen-
sitive to inhibition by direct S-glutathionylation of its Cys179 resi-
due. The treatment of diamide led to increase in 179CV mutant
CaMKI S-glutathionylation in situ (Fig. 5B). The Cys267 and Cys349
were both S-glutathionylated detected by mass spectrometry
(Table 1). Thus, CaMKI may be glutathionylated at not only the
Cys179 residue and the shift in mobility of the glutathionylated
CaMKI band in Fig. 2B is not likely a single GSH moiety. However,
it is the modiﬁcation at Cys179 that leads to inactivation. The CaMKI
is itself dependent on Ca2+/CaM in two ways. In addition of its own
catalytic activity being activated by Ca2+/CaM binding, CaMKK
phosphorylates CaMKI at Thr177 [17]. We propose another mecha-
nism of CaMKI regulation, oxidation-induced inactivation by glu-
tathionylation. Inhibition of CaMKI by oxidation appears to be
dominant over activation of the kinase by phosphorylation at
Thr177. This is based on the observation that oxidative inhibition
was not affected by the phosphorylation at Thr177 (Fig. 2C). The
phosphorylation of wild-type or 179CV mutant CaMKI at Thr177
was increased following stimulation with diamide in transfected
cells (Fig. 4A). It has been shown that oxidative stimulation can
cause activation of CaMKII and CaMKIV through inactivation of
protein phosphatases within the cells [22]. It is possible that the
oxidative inhibition of protein phosphatases in turn increased thephospho-Thr177 residue. For maximal activation, CaMKI must be
phosphorylated on its Thr177 residue [17]. However, diamide treat-
ment failed to activate 179CV in our cells (Fig. 4A). This is likely be-
cause the addition of Ca2+/CaM leads to full activation of 179CV by
phosphorylation at Thr177 by CaMKK, which is present in cell ly-
sates. We transfected a constitutively active form of CaMKK with
wild-type CaMKI for immunoprecipitation experiments (Fig. 4B)
since CaMKK is not present in immunoprecipitates. Thus, the phos-
phorylation of CaMKI at Thr177 was not altered following stimula-
tion with diamide in transfected cells (Fig. 4B). Although diamide
could oxidize and inhibit the protein phosphatase, which dephos-
phorylates phospho-Thr177, it inhibited CaMKI activity by direct
S-glutathionylation at Cys179 in cells. Note again that oxidant-in-
duced inhibition of CaMKI appears to be dominant over activation
of the kinase by phospho-Thr177 (Figs. 1A and 2C). Because DTT
was able to enhance the control activity of CaMKI (Fig. 1A), it is
suggested that oxidation of the enzyme readily occurs during stor-
age when the reducing agent is absent. In Fig. 5, there appears to be
an enhancement of phospho-Ser741 of nNOS, upon treatment of
cells expressing 179CV mutant of CaMKI with diamide.
Under what cellular conditions may CaMKI be glutathionylated
and inactivated? The mitochondria are the primary intracellular
source of reactive oxygen species, as they are responsible for huge
numbers of oxidative–reductive reactions and use massive
amounts of oxygen in the brain. Moreover, mitochondrial GSH con-
centrations may be higher than in the cytosol and there could also
be variation in the compartmentalization of glutathionylated pro-
tein, formed in response to diamide in cells [23]. It has recently
been shown that CaMKIa regulates mitochondrial dynamics and
morphology via phosphorylation of dynamin-related protein 1 in
the neuron [24]. It was shown that nNOS is phosphorylated by
CaMKI, leading to a reduction of nNOS activity through the phos-
2484 T. Kambe et al. / FEBS Letters 584 (2010) 2478–2484phorylation at Ser741 of the enzyme [21]. Since CaMKI-induced
nNOS phosphorylation at Ser741 was inhibited by the treatment
of diamide in situ (Fig. 5), oxidant stress might regulate the pro-
duction of NO via CaMKI inactivation. The physiological signiﬁ-
cance of CaMKI S-glutathionylation by oxidation stress, including
whether CaMKI is involved in such S-glutathionylation in vivo, re-
mains to be determined in the future.
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